123 related articles for article (PubMed ID: 16455599)
1. Preclinical anticancer activity of DNA-based cleavage molecules.
Dass CR
Drug Dev Ind Pharm; 2006 Jan; 32(1):1-5. PubMed ID: 16455599
[TBL] [Abstract][Full Text] [Related]
2. Deoxyribozymes: cleaving a path to clinical trials.
Dass CR
Trends Pharmacol Sci; 2004 Aug; 25(8):395-7. PubMed ID: 15276705
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human papillomavirus expression using DNAzymes.
Benítez-Hess ML; Reyes-Gutiérrez P; Alvarez-Salas LM
Methods Mol Biol; 2011; 764():317-35. PubMed ID: 21748650
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
Reyes-Gutiérrez P; Alvarez-Salas LM
Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
[TBL] [Abstract][Full Text] [Related]
5. Absence of unspecific innate immune cell activation by GATA-3-specific DNAzymes.
Dicke T; Pali-Schöll I; Kaufmann A; Bauer S; Renz H; Garn H
Nucleic Acid Ther; 2012 Apr; 22(2):117-26. PubMed ID: 22428550
[TBL] [Abstract][Full Text] [Related]
6. Effect of EBV LMP1 targeted DNAzymes on cell proliferation and apoptosis.
Lu ZX; Ye M; Yan GR; Li Q; Tang M; Lee LM; Sun LQ; Cao Y
Cancer Gene Ther; 2005 Jul; 12(7):647-54. PubMed ID: 15803142
[TBL] [Abstract][Full Text] [Related]
7. Catalytic DNA: a novel tool for gene suppression.
Cairns MJ; Saravolac EG; Sun LQ
Curr Drug Targets; 2002 Jun; 3(3):269-79. PubMed ID: 12041740
[TBL] [Abstract][Full Text] [Related]
8. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
9. Deoxyribozymes as Catalytic Nanotherapeutic Agents.
Khachigian LM
Cancer Res; 2019 Mar; 79(5):879-888. PubMed ID: 30760521
[TBL] [Abstract][Full Text] [Related]
10. DNAzymes as molecular agents that manipulate Egr-1 gene expression.
Khachigian LM
Biochem Pharmacol; 2004 Sep; 68(6):1023-5. PubMed ID: 15313396
[TBL] [Abstract][Full Text] [Related]
11. DNAzyme technology and cancer therapy: cleave and let die.
Dass CR; Choong PF; Khachigian LM
Mol Cancer Ther; 2008 Feb; 7(2):243-51. PubMed ID: 18281510
[TBL] [Abstract][Full Text] [Related]
12. Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents.
Zhang G; Dass CR; Sumithran E; Di Girolamo N; Sun LQ; Khachigian LM
J Natl Cancer Inst; 2004 May; 96(9):683-96. PubMed ID: 15126605
[TBL] [Abstract][Full Text] [Related]
13. Suppression of inducible nitric oxide synthase by 10-23 DNAzymes in murine macrophage.
Chaudhury I; Raghav SK; Gautam HK; Das HR; Das RH
FEBS Lett; 2006 Apr; 580(8):2046-52. PubMed ID: 16546178
[TBL] [Abstract][Full Text] [Related]
14. C-jun: pharmaceutical target for DNAzyme therapy of multiple pathologies.
Dass CR; Choong PF
Pharmazie; 2008 Jun; 63(6):411-4. PubMed ID: 18604982
[TBL] [Abstract][Full Text] [Related]
15. DNAzyme-based therapeutics for cancer treatment.
Fu S; Sun LQ
Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
[TBL] [Abstract][Full Text] [Related]
16. Nucleic acid enzymes as a novel generation of anti-gene agents.
Sioud M
Curr Mol Med; 2001 Nov; 1(5):575-88. PubMed ID: 11899232
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis.
Santiago FS; Khachigian LM
J Mol Med (Berl); 2001 Dec; 79(12):695-706. PubMed ID: 11862313
[TBL] [Abstract][Full Text] [Related]
18. The DNAzymes Rs6, Dz13, and DzF have potent biologic effects independent of catalytic activity.
Rivory L; Tucker C; King A; Lai A; Goodchild A; Witherington C; Gozar MM; Birkett DJ
Oligonucleotides; 2006; 16(4):297-312. PubMed ID: 17155906
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).
Wu Y; Yu L; McMahon R; Rossi JJ; Forman SJ; Snyder DS
Hum Gene Ther; 1999 Nov; 10(17):2847-57. PubMed ID: 10584930
[TBL] [Abstract][Full Text] [Related]
20. Deoxyribozymes as inhibitors of vascular smooth muscle cell growth.
Khachigian LM
Curr Pharm Biotechnol; 2004 Aug; 5(4):337-9. PubMed ID: 15320763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
